Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001130319-04-000577
Filing Date
2004-08-11
Accepted
2004-08-11 14:14:08
Documents
3
Period of Report
2004-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K - SECOND QUARTER REPORT FOR THE QUARTER ENDED JUNE 30, 2004 o13844e6vk.htm 6-K 161703
2 GRAPHIC o13844o1384401.gif GRAPHIC 4236
3 GRAPHIC o13844o1384402.gif GRAPHIC 1666
  Complete submission text file 0001130319-04-000577.txt   169394
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 04966661
SIC: 2834 Pharmaceutical Preparations